{
    "title": "Kudzu / Puerarin : Medical Applications",
    "inventor_name": "R. Wong, B. Rabie",
    "publication_year": 2007,
    "device_name": "Puerarin-Collagen Bone Graft",
    "goal": "Promote new bone formation in skeletal defects and support bone regeneration.",
    "problem_addressed": "Insufficient bone healing in defects, osteoporosis, and post-surgical bone loss.",
    "concept_summary": "Puerarin, a phytoestrogen isolated from Kudzu (Pueraria lobata), when mixed with a collagen matrix, markedly increases new bone formation in rabbit cranial defects. The compound also exhibits estrogen-receptor modulation and is investigated for various cardiovascular, metabolic and oncological indications.",
    "detailed_description": "In a controlled animal study, 18 parietal bone defects (5 mm x 10 mm) were created in nine New Zealand White rabbits. Six defects received a graft of puerarin solution mixed with a collagen matrix, six received collagen matrix alone, and six were left empty. After 14 days, histological analysis showed a 554 % increase in new bone volume in the puerarin-collagen group compared with the collagen-only control. The authors conclude that puerarin in a collagen scaffold can serve as an effective bone-inducing graft. Additional sections of the article discuss broader medical uses of Kudzu extracts, including estrogen-blocking activity, cardiovascular protection, alcoholism treatment, and intravenous puerarin for ischemic stroke, but these claims are largely based on preliminary or anecdotal evidence.",
    "category": "Medical & Dental Technologies",
    "principles": [
        "Phytoestrogen activity",
        "Estrogen receptor antagonism",
        "Scaffold-mediated osteogenesis",
        "Collagen matrix as carrier"
    ],
    "scientific_domains": [
        "Pharmacology",
        "Orthopedics",
        "Traditional Chinese Medicine",
        "Biochemistry"
    ],
    "mechanisms_of_action": [
        "Binding to estrogen receptors, modulating hormonal pathways",
        "Stimulation of osteoblast proliferation via phytoestrogen signaling",
        "Provision of a collagen scaffold for cell attachment and matrix deposition"
    ],
    "materials": [
        "Puerarin (C12H20C9, phytoestrogen)",
        "Collagen matrix (biopolymer scaffold)"
    ],
    "energy_sources": [],
    "inputs": [
        "Bone defect site",
        "Collagen matrix",
        "Puerarin solution"
    ],
    "outputs": [
        "New bone tissue",
        "Improved structural integrity of defect"
    ],
    "claimed_performance": "554 % more new bone formation in defects grafted with puerarin-collagen compared with collagen alone.",
    "experimental_evidence": "In a rabbit model (n=9), 18 cranial defects were treated; quantitative histological analysis after 14 days showed a 554 % increase in new bone volume for the puerarin-collagen group versus the collagen-only control.",
    "replication_status": null,
    "keywords": [
        "Puerarin",
        "Kudzu",
        "Bone regeneration",
        "Collagen scaffold",
        "Phytoestrogen",
        "Osteogenesis",
        "Animal study"
    ],
    "related_technologies": [
        "Tissue-engineered bone grafts",
        "Herbal medicinal extracts",
        "Estrogen-modulating therapeutics"
    ],
    "controversy_level": "low",
    "confidence_score": 0.93,
    "practicability_score": 0.65,
    "fringe_score": 0.15,
    "evidence_strength": 0.5,
    "risk_score": 0.2,
    "trl_estimate": 4,
    "source_urls": [
        "http://www.sciencedirect.com/science/article/pii/S1063458407000751",
        "http://cancerbooksource.com/defeat-cancer-book/excerpts/estrogen-herbs-homeopathy/",
        "http://www.webmd.com/vitamins-supplements/ingredientmono-750-kudzu.aspx?activeingredientid=750&activeingredientname=kudzu",
        "http://naturaldatabase.therapeuticresearch.com/nd/PrintVersion.aspx?id=750&AspxAutoDetectCookieSupport=1"
    ],
    "organizations": [],
    "applications": [
        "Bone grafting in orthopedic surgery",
        "Treatment of osteoporosis or bone-loss conditions",
        "Adjunct therapy for cardiovascular and metabolic disorders (investigational)"
    ],
    "limitations": [
        "Evidence limited to a single animal study",
        "No large-scale human clinical trials reported",
        "Potential side effects such as intravascular hemolysis with intravenous use"
    ],
    "open_questions": [
        "Efficacy and safety in humans for bone regeneration",
        "Optimal dosage and delivery method",
        "Long-term effects of repeated puerarin exposure"
    ],
    "red_flags": [],
    "evidence_quotes": [
        "A total of 554% more new bone was present in defects grafted with puerarin in collagen matrix than those grafted with the collagen matrix alone.",
        "No new bone was formed in the passive control group.",
        "Puerarin in collagen matrix has the effect of increasing new bone formation locally and can be used for bone grafting or for bone induction often required in surgery."
    ]
}